LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry into Alveolar Epithelium

    Giancotti, Filippo / Wang, Yan / Gurrapu, Sreeharsha / Chen, Hong / Laudato, Sara / Caggiano, Emily / Jiang, Yan / Ling, Hsiang-Hsi

    bioRxiv

    Abstract: Infection of the alveolar epithelium constitutes a bottleneck in the progression of COVID-19 to SARS presumably due to the paucity of viral entry receptors in alveolar epithelial type 1 and 2 cells. We have found that the male alveolar epithelial cells ... ...

    Abstract Infection of the alveolar epithelium constitutes a bottleneck in the progression of COVID-19 to SARS presumably due to the paucity of viral entry receptors in alveolar epithelial type 1 and 2 cells. We have found that the male alveolar epithelial cells express twice as many ACE2 and TMPRSS2 entry receptors as the female ones. Intriguingly, IFN and TNF-α signaling are preferentially active in male alveolar cells and induce binding of the cognate transcription factors to the promoters and lung-active enhancers of ACE2 and TMPRSS2. Cotreatment with IFN-I and III dramatically increases expression of the receptors and viral entry in alveolar epithelial cells. TNFα and IFN-II, typically overproduced during the cytokine storm, similarly collaborate to induce these events. Whereas JAK inhibitors suppress viral entry induced by IFN-I/III, simultaneous inhibition of IKK/NF-κB is necessary to block viral entry induced by TNFα and IFN II. In addition to explaining the increased incidence of SARS in males, these findings indicate that SARS-Cov-2 hijacks epithelial immune signaling to promote infection of the alveolar epithelium and suggest that JAK inhibitors, singly and in combination with NF-KB inhibitors, may exhibit efficacy in preventing or treating COVID-19 SARS.
    Keywords covid19
    Language English
    Publishing date 2021-07-23
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.07.23.453505
    Database COVID19

    Kategorien

  2. Article ; Online: Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.

    Ling, Hsiang-Hsi / Kuo, Chih-Chia / Lin, Bo-Xing / Huang, Yen-Hua / Lin, Cheng-Wei

    Experimental cell research

    2016  Volume 350, Issue 1, Page(s) 218–225

    Abstract: Tumor metastasis is the leading cause of death in cancer patients. Identifying metastatic biomarkers in tumor cells would help cancer diagnoses and the development of therapeutic targets. Yes-associated protein (YAP) plays an important role in organ ... ...

    Abstract Tumor metastasis is the leading cause of death in cancer patients. Identifying metastatic biomarkers in tumor cells would help cancer diagnoses and the development of therapeutic targets. Yes-associated protein (YAP) plays an important role in organ development and has gained much attention in tumorigenesis. However, the role of YAP and the underlying mechanism in tumor metastasis of colorectal cancer (CRC) is still unclear. In this study, we generated metastatic 116-LM cells from the HCT116 CRC cell line. We found that the capacity for tumor aggressiveness was elevated in 116-LM cells and identified that YAP and its mRNA level were upregulated in 116-LM cells. Moreover, expression of YAP was found to correlate with epithelial-mesenchymal transition (EMT) marker expressions, whereas suppression of YAP decreased EMT marker expressions and impeded tumor migration and invasion. Additionally, upregulation of YAP was identified in colon cancer patients, and it was correlated with EMT gene expressions. Furthermore, we identified LBH589, a histone deacetylase inhibitor, that was capable of inhibiting tumor growth and aggressiveness in both HCT116 and 116-LM cells. LBH589 potentially inhibited YAP and its mRNA expression, accompanied by diminished expressions of YAP downstream genes and EMT markers. Together, YAP plays a crucial role in aggressiveness and metastasis of CRC, and YAP may be an attractive therapeutic target.
    MeSH term(s) Adaptor Proteins, Signal Transducing/metabolism ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology ; Epithelial-Mesenchymal Transition ; HCT116 Cells ; Humans ; Hydroxamic Acids/pharmacology ; Indoles/pharmacology ; Panobinostat ; Phosphoproteins/metabolism ; RNA, Small Interfering/genetics ; Transcription Factors ; Up-Regulation
    Chemical Substances Adaptor Proteins, Signal Transducing ; Hydroxamic Acids ; Indoles ; Phosphoproteins ; RNA, Small Interfering ; Transcription Factors ; YAP1 protein, human ; Panobinostat (9647FM7Y3Z)
    Language English
    Publishing date 2016-11-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1493-x
    ISSN 1090-2422 ; 0014-4827
    ISSN (online) 1090-2422
    ISSN 0014-4827
    DOI 10.1016/j.yexcr.2016.11.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.

    Chen, Pin-Cyuan / Lee, Wen-Ying / Ling, Hsiang-Hsi / Cheng, Chia-Hsiung / Chen, Ku-Chung / Lin, Cheng-Wei

    Journal of cellular physiology

    2018  Volume 233, Issue 6, Page(s) 4972–4980

    Abstract: The tumor microenvironment plays an important role in tumor initiation and progression. It is well documented that nicotine participates in cigarette smoking-related malignancies. Previous studies focused on the effects of nicotine on tumor cells; ... ...

    Abstract The tumor microenvironment plays an important role in tumor initiation and progression. It is well documented that nicotine participates in cigarette smoking-related malignancies. Previous studies focused on the effects of nicotine on tumor cells; however, the role of the microenvironment in nicotine-mediated tumorigenesis is poorly understood. Herein, we investigated the effect and molecular mechanism of nicotine on fibroblasts and its contribution to breast cancer. We found that nicotine induced the epithelial-mesenchymal transition (EMT) of breast cancer cells and promoted activation of fibroblasts. Interestingly, conditioned medium from nicotine-activated fibroblasts (Nic-CM) had a greater impact on promoting the EMT and migratory capability toward cancer cells than did treatment with nicotine alone. Production of connective tissue growth factor (CTGF) and transforming growth factor (TGF)-β by nicotine-treated fibroblasts was demonstrated to be crucial for promoting the EMT and cancer cell migration, and blocking of CTGF and TGF-β in Nic-CM-suppressed tumor motility. Moreover, nicotine induced expressions of CTGF, and TGF-β in fibroblasts as identified through α7 nicotinic acetylcholine receptor (nAChR)-dependent activation of the AKT/TAZ signaling mechanism. Together, our data showed for the first time that activation of fibroblasts is largely responsible for accelerating smoking-mediated breast cancer progression.
    MeSH term(s) Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cancer-Associated Fibroblasts/drug effects ; Cancer-Associated Fibroblasts/metabolism ; Cancer-Associated Fibroblasts/pathology ; Carcinogens/toxicity ; Cell Movement/drug effects ; Connective Tissue Growth Factor/metabolism ; Culture Media, Conditioned/metabolism ; Epithelial-Mesenchymal Transition/drug effects ; Female ; Humans ; Intracellular Signaling Peptides and Proteins/metabolism ; MCF-7 Cells ; Neoplasm Invasiveness ; Nicotine/toxicity ; Paracrine Communication/drug effects ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects ; Smoking/adverse effects ; Transforming Growth Factor beta/metabolism ; Tumor Microenvironment ; alpha7 Nicotinic Acetylcholine Receptor/agonists ; alpha7 Nicotinic Acetylcholine Receptor/metabolism
    Chemical Substances CCN2 protein, human ; Carcinogens ; Chrna7 protein, human ; Culture Media, Conditioned ; Intracellular Signaling Peptides and Proteins ; Transforming Growth Factor beta ; WWTR1 protein, human ; alpha7 Nicotinic Acetylcholine Receptor ; Connective Tissue Growth Factor (139568-91-5) ; Nicotine (6M3C89ZY6R) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1)
    Language English
    Publishing date 2018-01-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3116-1
    ISSN 1097-4652 ; 0021-9541
    ISSN (online) 1097-4652
    ISSN 0021-9541
    DOI 10.1002/jcp.26334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.

    Kuo, Chih-Chia / Ling, Hsiang-Hsi / Chiang, Ming-Chen / Chung, Chu-Hung / Lee, Wen-Ying / Chu, Cheng-Ying / Wu, Yu-Chih / Chen, Cheng-Hsun / Lai, Yi-Wen / Tsai, I-Lin / Cheng, Chia-Hsiung / Lin, Cheng-Wei

    Theranostics

    2019  Volume 9, Issue 9, Page(s) 2526–2540

    Abstract: ... ...

    Abstract Rationale
    MeSH term(s) Adaptor Proteins, Signal Transducing/antagonists & inhibitors ; Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Adenocarcinoma/diagnosis ; Adenocarcinoma/genetics ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Animals ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Cell Proliferation ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Cell Transformation, Neoplastic/pathology ; Colonic Neoplasms/diagnosis ; Colonic Neoplasms/genetics ; Colonic Neoplasms/mortality ; Colonic Neoplasms/pathology ; Diet, High-Fat/adverse effects ; Gene Expression Regulation, Neoplastic ; Glucose Transporter Type 3/agonists ; Glucose Transporter Type 3/antagonists & inhibitors ; Glucose Transporter Type 3/genetics ; Glucose Transporter Type 3/metabolism ; Glycolysis/genetics ; HCT116 Cells ; HT29 Cells ; Humans ; Lymphatic Metastasis ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Mice ; Mice, Nude ; Prognosis ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Signal Transduction ; Survival Analysis ; Thyroid Hormones/genetics ; Thyroid Hormones/metabolism ; Transcription Factors/antagonists & inhibitors ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Xenograft Model Antitumor Assays ; YAP-Signaling Proteins ; Thyroid Hormone-Binding Proteins
    Chemical Substances Adaptor Proteins, Signal Transducing ; Carrier Proteins ; Glucose Transporter Type 3 ; Membrane Proteins ; RNA, Small Interfering ; SLC2A3 protein, human ; Thyroid Hormones ; Transcription Factors ; YAP-Signaling Proteins ; YAP1 protein, human
    Language English
    Publishing date 2019-04-13
    Publishing country Australia
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592097-2
    ISSN 1838-7640 ; 1838-7640
    ISSN (online) 1838-7640
    ISSN 1838-7640
    DOI 10.7150/thno.32915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top